Company Name
Madrigal Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US5588681057
CIK:
0001157601
CUSIP:
87162T206
Currency:
USD
Full Time Employees:
915
Phone:
267-824-2827
Website:
https://www.madrigalpharma.com
Fiscal Year End:
December
IPO Date:
Feb 06, 2007
Description:
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Address:
Four Tower Bridge, West Conshohocken, PA, United States, 19428